- Report
- September 2024
- 132 Pages
Global
From €7113EUR$7,950USD£6,083GBP
- Report
- August 2024
- 233 Pages
Global
From €7113EUR$7,950USD£6,083GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3355EUR$3,750USD£2,869GBP
- Report
- June 2023
- 159 Pages
Global
From €6711EUR$7,500USD£5,739GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2461EUR$2,750USD£2,104GBP
- Report
- September 2022
- 159 Pages
Global
From €6711EUR$7,500USD£5,739GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1118EUR$1,250USD£956GBP
- Report
- July 2025
- 350 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- June 2025
- 150 Pages
Global
From €2415EUR$2,699USD£2,065GBP
- Report
- June 2025
- 400 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- May 2024
- 128 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- May 2024
- 135 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- May 2024
- 139 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- May 2024
- 130 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- May 2024
- 140 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- February 2024
- 135 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2023
- 110 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- July 2024
- 48 Pages
Global
From €3575EUR$3,995USD£3,057GBP
- Drug Pipelines
- February 2023
- 127 Pages
Global
From €13417EUR$14,995USD£11,474GBP
- Report
- June 2025
- 245 Pages
Global
From €4469EUR$4,995USD£3,822GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more